.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

In short...

May 1, 2002

Fluorescent dye patent: Akorn has received a U.S. patent for fluorescent dye angiography and dye-enhanced photocoagulation for the diagnosis and treatment of abnormal vasculature. The dye, indocyanine green (ICG), could be used in the diagnosis and treatment of choroidal neovascularization associated with age-related macular degeneration. The dye would identify abnormal vasculature and target a laser to stop the blood flow that feeds it.